273 related articles for article (PubMed ID: 33123504)
1. Umbilical Cord Blood Transplants: Current Status and Evolving Therapies.
Gupta AO; Wagner JE
Front Pediatr; 2020; 8():570282. PubMed ID: 33123504
[TBL] [Abstract][Full Text] [Related]
2. [Umbilical cord blood as a source of stem cells].
Bojanić I; Golubić Cepulić B
Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.
Knutsen AP; Wall DA
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):823-32. PubMed ID: 10329816
[TBL] [Abstract][Full Text] [Related]
4. Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications.
Baron F; Ruggeri A; Nagler A
Expert Rev Hematol; 2016 Mar; 9(3):297-314. PubMed ID: 26635058
[TBL] [Abstract][Full Text] [Related]
5. Current status of umbilical cord blood hematopoietic stem cell transplantation.
Gluckman E
Exp Hematol; 2000 Nov; 28(11):1197-205. PubMed ID: 11063867
[TBL] [Abstract][Full Text] [Related]
6. Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.
Hexner EO; Luger SM; Reshef R; Jeschke GR; Mangan JK; Frey NV; Frank DM; Richman LP; Vonderheide RH; Aqui NA; Rosenbach M; Zhang Y; Chew A; Loren AW; Stadtmauer EA; Levine BL; June CH; Emerson SG; Porter DL
Am J Hematol; 2016 May; 91(5):453-60. PubMed ID: 26858124
[TBL] [Abstract][Full Text] [Related]
7. Umbilical cord blood transplantation--how, when and for whom?
Cohen Y; Nagler A
Blood Rev; 2004 Sep; 18(3):167-79. PubMed ID: 15183901
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem-cell transplantation using umbilical-cord blood.
Cohena Y; Nagler A
Leuk Lymphoma; 2003 Aug; 44(8):1287-99. PubMed ID: 12952221
[TBL] [Abstract][Full Text] [Related]
9. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
[TBL] [Abstract][Full Text] [Related]
10. Improving the outcome of umbilical cord blood transplantation through ex vivo expansion or graft manipulation.
Horwitz ME; Frassoni F
Cytotherapy; 2015 Jun; 17(6):730-738. PubMed ID: 25778757
[TBL] [Abstract][Full Text] [Related]
11. Ex Vivo Expansion of CD34
Bari S; Zhong Q; Fan X; Poon Z; Lim AST; Lim TH; Dighe N; Li S; Chiu GNC; Chai CLL; Hwang WYK
Stem Cells Transl Med; 2018 May; 7(5):376-393. PubMed ID: 29392885
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic transplant potential of unrelated cord blood: critical issues.
Kögler G; Callejas J; Hakenberg P; Enczmann J; Adams O; Däubener W; Krempe C; Göbel U; Somville T; Wernet P
J Hematother; 1996 Apr; 5(2):105-16. PubMed ID: 8723785
[TBL] [Abstract][Full Text] [Related]
13. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
Li Q; Zhao D; Chen Q; Luo M; Huang J; Yang C; Wang F; Li W; Liu T
Stem Cell Res Ther; 2019 Dec; 10(1):376. PubMed ID: 31806004
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood.
Wei YM; Cao Q; Zhou HY; Xia R; Lan JC; Meng FY; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1076-81. PubMed ID: 16403284
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy after hematopoietic stem cell transplantation using umbilical cord blood-derived products.
Saudemont A; Madrigal JA
Cancer Immunol Immunother; 2017 Feb; 66(2):215-221. PubMed ID: 27271550
[TBL] [Abstract][Full Text] [Related]
17. A modified CD34+ hematopoietic stem and progenitor cell isolation strategy from cryopreserved human umbilical cord blood.
Mata MF; Hernandez D; Rologi E; Grandolfo D; Hassan E; Hua P; Kallmeier R; Hirani S; Heuts F; Tittrea V; Choo Y; Baradez MO; Watt SM; Tarunina M
Transfusion; 2019 Dec; 59(12):3560-3569. PubMed ID: 31769050
[TBL] [Abstract][Full Text] [Related]
18. The future of cell therapy.
Yee GC
Pharmacotherapy; 1996; 16(3 Pt 2):109S-115S. PubMed ID: 8726590
[TBL] [Abstract][Full Text] [Related]
19. Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.
Almici C; Carlo-Stella C; Wagner JE; Mangoni L; Garau D; Re A; Giachetti R; Cesana C; Rizzoli V
Bone Marrow Transplant; 1997 Jun; 19(11):1079-84. PubMed ID: 9193749
[TBL] [Abstract][Full Text] [Related]
20. Advances in umbilical cord blood cell therapy: the present and the future.
Berglund S; Magalhaes I; Gaballa A; Vanherberghen B; Uhlin M
Expert Opin Biol Ther; 2017 Jun; 17(6):691-699. PubMed ID: 28379044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
